Haemonetics Corporation <HAE.N>: BofA Global Research Raises Price Objective to $100.00 From $93.00
HAE•Related News
PENN: Morgan Stanley Raises Target Price to $20.00 From $19.00
PENN•
American Homes 4 Rent <AMH.N>: Morgan Stanley cuts target price to $38.00 from $38.50
AMH•
Trimble Q2 profit beats on growth across segments
TRMB•
Milestone Pharmaceuticals Q2 FY26 net loss widens 120.7% to $28.61 million
MIST•
SUNation Energy Q2 revenue slips as residential solar demand weakens
SUNE•